☆ 4.8 Article

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

SCIENCE ADVANCES (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

Huiping Shuai et al.

Summary: The Omicron variant of SARS-CoV-2 shows reduced replication ability in human cells and attenuated pathogenicity in mice compared with the wild-type strain and other variants. It has lower efficiency in using TMPRSS2 and causes the lowest reduction in body weight and mortality rate among the tested strains.

NATURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants

Lianghui Zhang et al.

Summary: This study demonstrates that engineered ACE2 proteins with augmented binding affinities for SARS-CoV-2 spike protein show broad efficacy against multiple variants, indicating their therapeutic potential.

NATURE CHEMICAL BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Samuel M. S. Cheng et al.

Summary: Specific antibody levels against the SARS-CoV-2 Omicron variant decrease significantly after two doses of BNT162b2 or CoronaVac vaccines, but can be markedly increased with a booster dose of BNT162b2. Individuals who previously received two doses of BNT162b2 or CoronaVac showed reduced serum antibody titers against Omicron, while a BNT162b2 booster dose increased the antibody levels in the majority of individuals. This suggests mRNA vaccine boosters may be necessary in countries primarily using CoronaVac vaccines to combat the spread of Omicron.

NATURE MEDICINE (2022)

Add to Collection

Article Cell Biology

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection

Guillaume Beaudoin-Bussieres et al.

Summary: Emerging evidence suggests that both neutralizing and Fc-mediated effector functions of antibodies are important for protection against SARS-CoV-2. A non-neutralizing antibody, CV3-13, with potent Fc-mediated effector functions, was found to bind to a specific epitope of the SARS-CoV-2 spike from a unique angle. In mouse experiments, the Fc-enhanced version of CV3-13 delayed virus spread, neuroinvasion, and death, and the combination of Fc-enhanced CV3-13 with a neutralizing antibody completely protected mice from lethal SARS-CoV-2 infection.

CELL REPORTS (2022)

Add to Collection

Article Immunology

Novel Canine Coronavirus Isolated from a Hospitalized Patient With Pneumonia in East Malaysia

Anastasia N. Vlasova et al.

Summary: This study identified a novel canine-feline recombinant alphacoronavirus isolated from a child with pneumonia, suggesting recent zoonotic transmission and emphasizing the public health threat of animal CoVs. Better surveillance is needed to monitor these viruses and their potential impact on human health.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Biology

Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction

Shuang Wang et al.

Summary: Understanding the ADE mechanism of SARS-CoV-2 is crucial for developing safe and effective therapies. Two neutralizing antibodies, MW01 and MW05, were found to enhance the infection of SARS-CoV-2 pseudovirus, while MW07 showed no ADE activity. Monovalent MW01 and MW05 completely eliminated ADE activity. Macropinocytosis and endocytosis were confirmed to be involved in ADE of SARS-CoV-2 pseudoviral infection.

COMMUNICATIONS BIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent

Tianshu Xiao et al.

Summary: This study introduces a trimeric ACE2 ectodomain variant engineered using a structure-based approach, which has a high binding affinity for the spike protein of SARS-CoV-2, preserved peptidase activity, and the ability to block angiotensin II receptor activation. The engineered ACE2 also shows potent inhibition of SARS-CoV-2 infection in cell culture, suggesting it may be a promising therapeutic agent for COVID-19.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)

Add to Collection

Article Urology & Nephrology

A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids

Jan Wysocki et al.

Summary: A novel ACE2 variant has been developed that can neutralize SARS-CoV-2 infectivity in human kidney organoids, with prolonged duration of action and potential for improved efficacy.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2

Donald J. Benton et al.

Summary: Studies indicate that the G614 mutant spike adopts more open conformations, which may facilitate binding to the SARS-CoV-2 receptor ACE2 and the subsequent structural rearrangements required for viral membrane fusion.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Seiya Ozono et al.

Summary: The naturally occurring mutations of SARS-CoV-2 spike protein can affect cell entry, with the D614G mutation resulting in increased cell entry and maintaining susceptibility to neutralization by antisera against prototypic viruses. Further global surveillance is needed to understand the transmissibility of SARS-CoV-2 among humans.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury

Tomokazu Yamaguchi et al.

Summary: Endogenous ACE2 is a receptor for SARS-CoV-2 and a recombinant soluble ACE2 protein can act as a decoy to inhibit virus infection. The ACE2-like enzyme B38-CAP is shown to be protective against SARS-CoV-2-induced lung injury, providing potential therapeutic strategies for COVID-19 patients.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals

Savannah E. Butler et al.

Summary: Understanding humoral immune responses to SARS-CoV-2 infection is crucial for vaccine development and antibody-based interventions. Antibody responses in convalescent individuals varied depending on disease severity, with systemic and mucosal responses showing different characteristics. Neutralization and antibody-mediated effector functions in serum correlated with IgG response magnitude, while nasal neutralization was associated with IgA response, highlighting the importance of assessing mucosal immunity in larger natural infection cohorts.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants

Kui K. Chan et al.

Summary: The study suggests that engineered decoy receptors can tightly bind to the S protein of SARS-related viruses, and are expected to be effective against future coronavirus outbreaks.

SCIENCE ADVANCES (2021)

Add to Collection

Article Biophysics

The flexibility of ACE2 in the context of SARS-CoV-2 infection

Emilia P. Barros et al.

Summary: The COVID-19 pandemic has caused significant loss of life worldwide, and there are still unanswered questions regarding the viral association to ACE2 receptor. Molecular dynamics simulations reveal the flexibility of the ACE2 receptor and its dynamics on the cell surface, which could provide insights for the development of therapeutics against SARS-CoV-2.

BIOPHYSICAL JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection

Ami Miller et al.

Summary: A novel protein engineering technology has been used to produce a tetravalent ACE2-Fc-TD protein that effectively blocks SARS-CoV-2 virus infection. This tetrameric protein complex acts as a powerful decoy protein, capable of binding to the virus and preventing its invasion.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Microbiology

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2

Huihui Mou et al.

Summary: The research suggests that pangolins may serve as an intermediate host between humans and bats, and that bat ACE2 orthologs could provide insights useful for enhancing the potency of ACE2-based therapeutics.

PLOS PATHOGENS (2021)

Add to Collection

Review Immunology

A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain

Ling Niu et al.

Summary: This review summarizes the current understanding of the structural landscape of neutralizing antibodies targeting the RBD of SARS-CoV-2 spike glycoprotein. It discusses the potential impact of identifying sites of vulnerability and the formation of better vaccines and immunotherapeutics. The review also highlights the importance of additional analysis of vaccine-induced nAbs in the development of improved vaccines.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

Dapeng Li et al.

Summary: Research has shown that some SARS-CoV-2 neutralizing antibodies can enhance virus infection in vitro, but in monkeys and mice, these antibodies can still protect against SARS-CoV-2. However, out of 46 monkeys infused with enhancing antibodies, three showed higher lung inflammation scores compared to controls.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Yafei Liu et al.

Summary: The research found that antibodies against different domains of the SARS-CoV-2 spike protein have different effects, with some antibodies inducing an open conformation of the RBD and enhancing the virus infectivity. Structural and mutational analysis revealed the mechanisms of these antibodies, and infectivity-enhancing antibodies were detected at higher levels in severe patients.

CELL (2021)

Add to Collection

Article Immunology

Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy

Irfan Ullah et al.

Summary: Neutralizing antibodies are effective in treating COVID-19, but the mechanism of immune protection is not fully understood. Real-time imaging revealed that highly potent NAbs can prevent and resolve established infections when administered within three days. Both Fab and Fc effector functions of NAbs are essential for optimal efficacy against SARS-CoV-2.

IMMUNITY (2021)

Add to Collection

Article Chemistry, Medicinal

Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar Affinity

Brandon Havranek et al.

Summary: Researchers have computationally designed a promising therapeutic candidate, a derivative of ACE2, with higher binding affinity than the wild type for treating COVID-19, indicating its potential to buffer against the emergence of SARS-CoV-2 variants. The computational methods used have shown sufficient accuracy for the design of therapeutics for current and future viral pandemics.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2

Yusuke Higuchi et al.

Summary: The engineered human virus receptor ACE2 successfully neutralized SARS-CoV-2 at a lower concentration, preventing escape mutants from emerging. Furthermore, therapeutic administration of engineered ACE2 protected hamsters from infection and decreased lung virus titers and pathology.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Cell Biology

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo

Zhaoyong Zhang et al.

Summary: The developed hACE2-Fc fusion protein and mutant show potent antiviral effects against various coronaviruses, including SARS-CoV-2 variants, in cell experiments and mouse models. The drug has a relatively long half-life, making it suitable for prophylaxis and therapy for COVID-19, SARS-CoV, and HCoV-NL63 infections.

CELL DISCOVERY (2021)

Add to Collection

Article Immunology

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions

Rebekah Sherburn et al.

Summary: The research has shown that vaccination strategies inducing non-neutralizing or weakly neutralizing antibodies with potent Fc-effector functions have been partially successful in preventing and controlling HIV-1 infection. By incorporating V1V2 domain into the ID2 antigen, the newly generated ID2-V1V2 vaccine immunogen significantly enhances the Fc-mediated effector functions, showing promise as a candidate for HIV-1 vaccine development.

VACCINES (2021)

Add to Collection

Review Microbiology

A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development

Zainalabideen A. Abdulla et al.

Summary: The world is in a race to develop COVID-19 vaccines, with 14 authorized for use and over 40 in clinical trials. Factors for choosing vaccines include mode of action, dosage protocol, and side effects. Mutated variants of the virus are a concern, and the long-term protection and potential modifications of current vaccines are being studied.

PATHOGENS (2021)

Add to Collection

Article Biochemical Research Methods

A new flow cytometry assay to measure antibody- dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells

Guillaume Beaudoin-Bussieres et al.

Summary: Antibodies can engage specific receptors on effector cells and have functions beyond viral neutralization, such as antibody-dependent cellular cytotoxicity (ADCC), which plays an important role in protection against SARS-CoV-2 infections. By using a cell line expressing GFP-tagged SARS-CoV-2 spike, ADCC activity mediated by anti-SARS-CoV-2 Spike monoclonal antibodies or plasma from previously infected or vaccinated individuals can be measured in an optimized manner. Detailed information on the protocol can be found in Anand et al. (2021b).

STAR PROTOCOLS (2021)

Add to Collection

Article Cell Biology

A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions

Ssu-Hsueh Tseng et al.

Summary: This study developed a preclinical animal model using intranasal administration of ACE2 followed by non-infectious SARS-CoV-2 pseudovirus challenge. The model demonstrated the ability to infect the respiratory passage of mice and can be used to test interventions or preventative treatments for SARS-CoV-2 infections.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Vanessa Monteil et al.

CELL (2020)

Add to Collection

Article Microbiology

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies

Thach H. Chu et al.

PLOS PATHOGENS (2020)

Add to Collection

Article Medicine, Research & Experimental

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

Daniel Batlle et al.

CLINICAL SCIENCE (2020)

Add to Collection

Article Virology

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Katharine H. D. Crawford et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Multidisciplinary Sciences

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig

Changhai Lei et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Add to Collection

Editorial Material Medicine, Research & Experimental

Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy

Jameel M. Inal

CLINICAL SCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

Sarah R. Leist et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

Kui K. Chan et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Ching-Lin Hsieh et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

Anum Glasgow et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Multidisciplinary Sciences

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Longxing Cao et al.

SCIENCE (2020)

Add to Collection

Article Critical Care Medicine

Human recombinant soluble ACE2 in severe COVID-19

Alexander Zoufaly et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Review Immunology

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19

Donato Zipeto et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Microbiology

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Wen Shi Lee et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

Fatai S. Oladunni et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Biochemical Research Methods

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation

Stephanie Fischinger et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2019)

Add to Collection

Review Immunology

Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life

Kevin O. Saunders

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Biochemical Research Methods

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

Dorothee Liebschner et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)

Add to Collection

Article Microbiology

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

Simone I. Richardson et al.

PLOS PATHOGENS (2019)

Add to Collection

Article Biochemical Research Methods

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis

Francesca Ferrara et al.

METHODS AND PROTOCOLS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice

Megan Lo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Add to Collection

Article Multidisciplinary Sciences

Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion

Alexandra C. Walls et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Add to Collection

Article Multidisciplinary Sciences

A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13

Pan Liu et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Multidisciplinary Sciences

Linking Crystallographic Model and Data Quality

P. Andrew Karplus et al.

SCIENCE (2012)

Add to Collection

Article Biochemical Research Methods

Overview of the CCP4 suite and current developments

Martyn D. Winn et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Add to Collection

Article Biochemical Research Methods

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Margaret E. Ackerman et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2011)

Add to Collection

Article Biochemical Research Methods

MolProbity: all-atom structure validation for macromolecular crystallography

Vincent B. Chen et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)

Add to Collection

Article Biotechnology & Applied Microbiology

Enhanced antibody half-life improves in vivo activity

Jonathan Zalevsky et al.

NATURE BIOTECHNOLOGY (2010)

Add to Collection

Article Chemistry, Physical

Peptide hydrolysis by the binuclear zinc enzyme aminopeptidase from Aeromonas proieolytica:: A density functional theory study

Shi-Lu Chen et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2008)

Add to Collection

Article Virology

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Paul B. McCray et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Biochemical Research Methods

HKL-3000:: the integration of data reduction and structure solution -: from diffraction images to an initial model in minutes

Wladek Minor et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)

Add to Collection

Article Biochemistry & Molecular Biology

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

K Kuba et al.

NATURE MEDICINE (2005)

Add to Collection

Article Virology

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2

MJ Moore et al.

JOURNAL OF VIROLOGY (2004)

Add to Collection

Article Biochemical Research Methods

Choice of data-collection parameters based on statistic modelling

AN Popov et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)

Add to Collection

Article Chemistry, Multidisciplinary

Global indicators of X-ray data quality

MS Weiss

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.